Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer

Stem Cells Translational Medicine(2023)10.1093/stcltm/szad033Source: DataRank Database

Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer is a research paper published in Stem Cells Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.50)OA: goldTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Yohei Kitamura ORCID,Paulo Borges,Sophia Auduong,Seyda Kilic ORCID,David Y.B. Deng ORCID

Live enrichment

PubMed:37311043 PMC:PMC10346421 OpenAlex:https://openalex.org/W4380538006

DoD

Grant: LC180495

NIH

Grant: R01-CA201148

NCI NIH HHS

Grant: R01 CA201148

National Institutes of Health

Grant: 7R01CA201148-02

Fate and efficacy of targeted therapies for metastatic tumors

FWCI

0.50

Citation Percentile

0.6%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://academic.oup.com/stcltm/advance-article-pdf/doi/10.1093/stcltm/szad033/50596526/szad033.pdf

publisherhttps://academic.oup.com/stcltm/advance-article-pdf/doi/10.1093/stcltm/szad033/50596526/szad033.pdf

publisherhttps://academic.oup.com/stcltm/article-pdf/12/7/444/50876756/szad033.pdf

journalhttps://doi.org/10.1093/stcltm/szad033

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37311043

Fields of Study

Lung Cancer Treatments and MutationsLung Cancer Research StudiesCancer Cells and Metastasis03 medical and health sciences0302 clinical medicine

MeSH Terms

BrainBrain NeoplasmsCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsCell DeathHematopoietic Stem Cell TransplantationCell ProliferationErbB Receptors

Keywords

Stem cellCancer stem cellCancer researchLung cancerMedicineBiologyOncologyCell biologyNSCLCStem CellsLeptomeningeal MetastasesEvdrlErbB ReceptorsLung NeoplasmsCell DeathBrain NeoplasmsCarcinoma, Non-Small-Cell LungHematopoietic Stem Cell TransplantationHumansBrainEnabling Technologies for Cell-Based Clinical TranslationCell Proliferation

Sustainable Development Goals

SDG 0: Good health and well-being